You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東誠藥業(002675.SZ):安迪科的武漢核藥房投入運營
格隆匯 03-15 16:36

格隆匯3月15日丨東誠藥業(002675.SZ)公佈,公司收到全資子公司安迪科的通知,通知其子公司湖北安迪科收到湖北省藥品監督管理局發送的《藥品GMP符合性檢查結果書》。檢查範圍:小容量注射劑(放射性藥品:氟【18F】脱氧葡糖注射液),經審核,本次藥品GMP符合性檢查符合《藥品生產質量管理規範》(2010年修訂)要求。

此次湖北安迪科通過GMP符合性檢查,標誌着安迪科的武漢核藥房已達到投產要求,安迪科將新增一個核藥房。核藥房投產後,將有利於安迪科開拓湖北市場、提升銷售收入,進一步完善全國核藥網絡化建設佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account